Debra Doby is recognized nationally as an authority on legal issues involving opioids and cannabis. As member of Goldberg Segalla's Intellectual Property Practice Group, she works to protect the ideas, innovations, inventions, and creative property that have fueled her clients’ successes. This includes litigation and arbitration involving patents, trademarks and copyrights, trade secrets, licensing and portfolio management, and unfair competition — especially in matters of international trade. Drawing on a bachelor's in chemistry from the University of West Georgia, a J.D. and Certificate in International and Comparative Law from Vermont Law School, and an LL.M. focusing on international arbitration and cross-border disputes from Trinity College Dublin, Doby combines her mastery of technical vocabulary and concepts with an intimate understanding of complex cross-border dynamics to advise clients working at the forefront of some of the chief intellectual property issues shaping domestic and international business.
Michael Siem, a partner at Goldberg Segalla, is a nationally renowned intellectual property litigator and registered patent attorney with a focus on complex and high-value patent litigation. Siem has litigated cases in many technological areas, including pharmaceuticals, consumer electronics, chemical processes, computer networks, and biotechnology. He currently serves as lead trial counsel in several ongoing matters representing some of the largest pharmaceutical manufacturers in the world. In addition, Siem's intellectual property practice extends to drafting and filing patent and trademark applications as well as trademark litigation under the Anticybersquatting Consumer Protection Act. He is a graduate of the Illinois Institute of Technology (with a B.S. in Chemical Engineering) and earned his juris doctor at the University of Michigan Law School.